hif 1 α antibody Search Results


membranes  (Proteintech)
96
Proteintech membranes
Membranes, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/membranes/product/Proteintech
Average 96 stars, based on 1 article reviews
membranes - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
anti hif 1α  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology anti hif 1α
Anti Hif 1α, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hif 1α/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
anti hif 1α - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
hif 1α  (Proteintech)
96
Proteintech hif 1α
Hif 1α, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hif 1α/product/Proteintech
Average 96 stars, based on 1 article reviews
hif 1α - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
hif-1α yt2133 antibody  (ImmunoWay Biotechnology Company)
90
ImmunoWay Biotechnology Company hif-1α yt2133 antibody
Hif 1α Yt2133 Antibody, supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hif-1α yt2133 antibody/product/ImmunoWay Biotechnology Company
Average 90 stars, based on 1 article reviews
hif-1α yt2133 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-hif1a  (Becton Dickinson)
90
Becton Dickinson anti-hif1a
Anti Hif1a, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hif1a/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-hif1a - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hif-1α (1:500; catlog no. 10006421;  (Cayman Chemical)
90
Cayman Chemical hif-1α (1:500; catlog no. 10006421;
Hif 1α (1:500; Catlog No. 10006421;, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hif-1α (1:500; catlog no. 10006421;/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
hif-1α (1:500; catlog no. 10006421; - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-hif2-a  (GeneTex)
90
GeneTex anti-hif2-a
Anti Hif2 A, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hif2-a/product/GeneTex
Average 90 stars, based on 1 article reviews
anti-hif2-a - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
primary antibodies against hif-1α gb13031-1  (Servicebio Inc)
90
Servicebio Inc primary antibodies against hif-1α gb13031-1
a Biodistribution of DR-CoMo-LDH-PEG in mice by monitoring the Co concentration at various time points post-injection. Data are presented as mean values ± s.d. ( n = 3). Statistical analysis was performed via one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. b Tumor growth curves of mice after various treatments. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. c Representative photographs of mice with treatments at various time points and d corresponding average weight of tumors taken on Day 16. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. e Body weight change of 4T1 tumor-bearing mice after different treatments. Data are presented as mean values ± s.d. ( n = 6). f <t>HIF-1α,</t> g DHE, and h H&E, Ki-67, TUNEL and CD31 staining assay of tumor slices from various groups of mice after 16 days of treatment: 1) PBS, 2) 1567 nm laser (0.5 W cm −2 for 6 min), 3) DR-CoMo-LDH-PEG, 4) DR-CoMo-LDH-PEG + 1567 nm laser. Each experiment was repeated three times with similar results. Source data are provided as a Source Data file.
Primary Antibodies Against Hif 1α Gb13031 1, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against hif-1α gb13031-1/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
primary antibodies against hif-1α gb13031-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-hif-1α monoclonal antibody ls-b145/10218  (Absolute Biotech Inc)
90
Absolute Biotech Inc anti-hif-1α monoclonal antibody ls-b145/10218
a Biodistribution of DR-CoMo-LDH-PEG in mice by monitoring the Co concentration at various time points post-injection. Data are presented as mean values ± s.d. ( n = 3). Statistical analysis was performed via one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. b Tumor growth curves of mice after various treatments. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. c Representative photographs of mice with treatments at various time points and d corresponding average weight of tumors taken on Day 16. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. e Body weight change of 4T1 tumor-bearing mice after different treatments. Data are presented as mean values ± s.d. ( n = 6). f <t>HIF-1α,</t> g DHE, and h H&E, Ki-67, TUNEL and CD31 staining assay of tumor slices from various groups of mice after 16 days of treatment: 1) PBS, 2) 1567 nm laser (0.5 W cm −2 for 6 min), 3) DR-CoMo-LDH-PEG, 4) DR-CoMo-LDH-PEG + 1567 nm laser. Each experiment was repeated three times with similar results. Source data are provided as a Source Data file.
Anti Hif 1α Monoclonal Antibody Ls B145/10218, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-hif-1α monoclonal antibody ls-b145/10218/product/Absolute Biotech Inc
Average 90 stars, based on 1 article reviews
anti-hif-1α monoclonal antibody ls-b145/10218 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
antibodies against human hif-1  (Upstate Biotechnology Inc)
90
Upstate Biotechnology Inc antibodies against human hif-1
a Biodistribution of DR-CoMo-LDH-PEG in mice by monitoring the Co concentration at various time points post-injection. Data are presented as mean values ± s.d. ( n = 3). Statistical analysis was performed via one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. b Tumor growth curves of mice after various treatments. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. c Representative photographs of mice with treatments at various time points and d corresponding average weight of tumors taken on Day 16. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. e Body weight change of 4T1 tumor-bearing mice after different treatments. Data are presented as mean values ± s.d. ( n = 6). f <t>HIF-1α,</t> g DHE, and h H&E, Ki-67, TUNEL and CD31 staining assay of tumor slices from various groups of mice after 16 days of treatment: 1) PBS, 2) 1567 nm laser (0.5 W cm −2 for 6 min), 3) DR-CoMo-LDH-PEG, 4) DR-CoMo-LDH-PEG + 1567 nm laser. Each experiment was repeated three times with similar results. Source data are provided as a Source Data file.
Antibodies Against Human Hif 1, supplied by Upstate Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against human hif-1/product/Upstate Biotechnology Inc
Average 90 stars, based on 1 article reviews
antibodies against human hif-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hif-1α antibody  (ZenBio)
90
ZenBio hif-1α antibody
Diabetes impedes neovascularization level in spinal cord of SCI rat. (A and B) Representative western blotting results and quantitative analysis of <t>HIF-1α,</t> ANG1 and VEGF in spinal cord at 3 days after SCI. (C and D) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in HUVECs. (E) Co-staining of HIF-1α (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (F) Co-staining of ANG1 (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (G) The tube formation ability of HUVECs, Scale bar = 200μm. (H) Quantification of tube length from tube formation assay. n≥3, *P<0.05, **P<0.01, ***P<0.001.
Hif 1α Antibody, supplied by ZenBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hif-1α antibody/product/ZenBio
Average 90 stars, based on 1 article reviews
hif-1α antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
hif1α  (Beyotime)
90
Beyotime hif1α
Diabetes impedes neovascularization level in spinal cord of SCI rat. (A and B) Representative western blotting results and quantitative analysis of <t>HIF-1α,</t> ANG1 and VEGF in spinal cord at 3 days after SCI. (C and D) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in HUVECs. (E) Co-staining of HIF-1α (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (F) Co-staining of ANG1 (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (G) The tube formation ability of HUVECs, Scale bar = 200μm. (H) Quantification of tube length from tube formation assay. n≥3, *P<0.05, **P<0.01, ***P<0.001.
Hif1α, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hif1α/product/Beyotime
Average 90 stars, based on 1 article reviews
hif1α - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a Biodistribution of DR-CoMo-LDH-PEG in mice by monitoring the Co concentration at various time points post-injection. Data are presented as mean values ± s.d. ( n = 3). Statistical analysis was performed via one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. b Tumor growth curves of mice after various treatments. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. c Representative photographs of mice with treatments at various time points and d corresponding average weight of tumors taken on Day 16. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. e Body weight change of 4T1 tumor-bearing mice after different treatments. Data are presented as mean values ± s.d. ( n = 6). f HIF-1α, g DHE, and h H&E, Ki-67, TUNEL and CD31 staining assay of tumor slices from various groups of mice after 16 days of treatment: 1) PBS, 2) 1567 nm laser (0.5 W cm −2 for 6 min), 3) DR-CoMo-LDH-PEG, 4) DR-CoMo-LDH-PEG + 1567 nm laser. Each experiment was repeated three times with similar results. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: Defect engineering of layered double hydroxide nanosheets as inorganic photosensitizers for NIR-III photodynamic cancer therapy

doi: 10.1038/s41467-022-31106-9

Figure Lengend Snippet: a Biodistribution of DR-CoMo-LDH-PEG in mice by monitoring the Co concentration at various time points post-injection. Data are presented as mean values ± s.d. ( n = 3). Statistical analysis was performed via one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. b Tumor growth curves of mice after various treatments. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. c Representative photographs of mice with treatments at various time points and d corresponding average weight of tumors taken on Day 16. Data are presented as mean values ± s.d. ( n = 6). Statistical analysis was performed via one-way ANOVA. ***p < 0.001. e Body weight change of 4T1 tumor-bearing mice after different treatments. Data are presented as mean values ± s.d. ( n = 6). f HIF-1α, g DHE, and h H&E, Ki-67, TUNEL and CD31 staining assay of tumor slices from various groups of mice after 16 days of treatment: 1) PBS, 2) 1567 nm laser (0.5 W cm −2 for 6 min), 3) DR-CoMo-LDH-PEG, 4) DR-CoMo-LDH-PEG + 1567 nm laser. Each experiment was repeated three times with similar results. Source data are provided as a Source Data file.

Article Snippet: The tumor slices were stained with primary antibodies (against HIF-1α (GB13031-1, Servicebio, China, 1:200 dilution)) at 4 °C overnight, followed by phalloidin at 25 °C for 1 h. Images were captured via CLSM.

Techniques: Concentration Assay, Injection, TUNEL Assay, Staining

Diabetes impedes neovascularization level in spinal cord of SCI rat. (A and B) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in spinal cord at 3 days after SCI. (C and D) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in HUVECs. (E) Co-staining of HIF-1α (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (F) Co-staining of ANG1 (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (G) The tube formation ability of HUVECs, Scale bar = 200μm. (H) Quantification of tube length from tube formation assay. n≥3, *P<0.05, **P<0.01, ***P<0.001.

Journal: International Journal of Biological Sciences

Article Title: Over-activation of TRPM2 ion channel accelerates blood-spinal cord barrier destruction in diabetes combined with spinal cord injury rat

doi: 10.7150/ijbs.80672

Figure Lengend Snippet: Diabetes impedes neovascularization level in spinal cord of SCI rat. (A and B) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in spinal cord at 3 days after SCI. (C and D) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in HUVECs. (E) Co-staining of HIF-1α (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (F) Co-staining of ANG1 (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (G) The tube formation ability of HUVECs, Scale bar = 200μm. (H) Quantification of tube length from tube formation assay. n≥3, *P<0.05, **P<0.01, ***P<0.001.

Article Snippet: Then, the membranes were blocked with 5% skimmed milk in TBST for 2 h at room temperature, and incubated with the following primary antibodies at 4°C overnight: TRPM2 (1:1000, NB500-242), p-CaMKII (1:1000, sc-32289), CaMKII (1:1000, sc-5306), eNOS (1:1000, sc-376751), NOX2 (1:1000, ab129068), HIF-1α (1:1000, ZEN BIO, 340462), ANG1 (1:5000, ab183701), VEGF (1:1000, sc-7269), Cleaved(C)-caspase3 (1:1000, 9664S), β-catenin (1:1000, ab32572), ZO-1 (1:1000, AF5145), Claudin-5 (1:1000, AF5216), occluding (1:1000, DF7504), P120 (1:1000, AF4684).

Techniques: Western Blot, Staining, Tube Formation Assay

TRPM2 inhibition improves angiogenesis level under diabetes combined with SCI condition. (A and B) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in spinal cord of rat at 3 days after SCI. (C and D) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in HUVECs. (E) Co-staining of HIF-1α (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (F) Co-staining of ANG1 (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (G) The tube formation ability of HUVECs, Scale bar = 200 μm. (H) Quantification of tube length from tube formation assay. n≥3, *P<0.05, **P<0.01, ***P<0.001.

Journal: International Journal of Biological Sciences

Article Title: Over-activation of TRPM2 ion channel accelerates blood-spinal cord barrier destruction in diabetes combined with spinal cord injury rat

doi: 10.7150/ijbs.80672

Figure Lengend Snippet: TRPM2 inhibition improves angiogenesis level under diabetes combined with SCI condition. (A and B) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in spinal cord of rat at 3 days after SCI. (C and D) Representative western blotting results and quantitative analysis of HIF-1α, ANG1 and VEGF in HUVECs. (E) Co-staining of HIF-1α (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (F) Co-staining of ANG1 (green) and CD31 (red) in spinal cord at 3 days after SCI, Scale bar = 10 μm. (G) The tube formation ability of HUVECs, Scale bar = 200 μm. (H) Quantification of tube length from tube formation assay. n≥3, *P<0.05, **P<0.01, ***P<0.001.

Article Snippet: Then, the membranes were blocked with 5% skimmed milk in TBST for 2 h at room temperature, and incubated with the following primary antibodies at 4°C overnight: TRPM2 (1:1000, NB500-242), p-CaMKII (1:1000, sc-32289), CaMKII (1:1000, sc-5306), eNOS (1:1000, sc-376751), NOX2 (1:1000, ab129068), HIF-1α (1:1000, ZEN BIO, 340462), ANG1 (1:5000, ab183701), VEGF (1:1000, sc-7269), Cleaved(C)-caspase3 (1:1000, 9664S), β-catenin (1:1000, ab32572), ZO-1 (1:1000, AF5145), Claudin-5 (1:1000, AF5216), occluding (1:1000, DF7504), P120 (1:1000, AF4684).

Techniques: Inhibition, Western Blot, Staining, Tube Formation Assay